Sort by
Items per page

Send to

Choose Destination

Links from

Items: 1 to 20 of 173


Association between Promoter Methylation of Gene ERCC3 and Benzene Hematotoxicity.

Zheng M, Lin F, Hou F, Li G, Zhu C, Xu P, Xing C, Wang Q.

Int J Environ Res Public Health. 2017 Aug 16;14(8). pii: E921. doi: 10.3390/ijerph14080921.


Transcription without XPB Establishes a Unified Helicase-Independent Mechanism of Promoter Opening in Eukaryotic Gene Expression.

Alekseev S, Nagy Z, Sandoz J, Weiss A, Egly JM, Le May N, Coin F.

Mol Cell. 2017 Feb 2;65(3):504-514.e4. doi: 10.1016/j.molcel.2017.01.012.


A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.

Vijai J, Topka S, Villano D, Ravichandran V, Maxwell KN, Maria A, Thomas T, Gaddam P, Lincoln A, Kazzaz S, Wenz B, Carmi S, Schrader KA, Hart SN, Lipkin SM, Neuhausen SL, Walsh MF, Zhang L, Lejbkowicz F, Rennert H, Stadler ZK, Robson M, Weitzel JN, Domchek S, Daly MJ, Couch FJ, Nathanson KL, Norton L, Rennert G, Offit K.

Cancer Discov. 2016 Nov;6(11):1267-1275. Epub 2016 Sep 21.


Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.

Beglyarova N, Banina E, Zhou Y, Mukhamadeeva R, Andrianov G, Bobrov E, Lysenko E, Skobeleva N, Gabitova L, Restifo D, Pressman M, Serebriiskii IG, Hoffman JP, Paz K, Behrens D, Khazak V, Jablonski SA, Golemis EA, Weiner LM, Astsaturov I.

Clin Cancer Res. 2016 Dec 15;22(24):6153-6163. Epub 2016 Jul 6.


A small molecule screen identifies an inhibitor of DNA repair inducing the degradation of TFIIH and the chemosensitization of tumor cells to platinum.

Alekseev S, Ayadi M, Brino L, Egly JM, Larsen AK, Coin F.

Chem Biol. 2014 Mar 20;21(3):398-407. doi: 10.1016/j.chembiol.2013.12.014. Epub 2014 Feb 6.


Global regulation of promoter melting in naive lymphocytes.

Kouzine F, Wojtowicz D, Yamane A, Resch W, Kieffer-Kwon KR, Bandle R, Nelson S, Nakahashi H, Awasthi P, Feigenbaum L, Menoni H, Hoeijmakers J, Vermeulen W, Ge H, Przytycka TM, Levens D, Casellas R.

Cell. 2013 May 23;153(5):988-99. doi: 10.1016/j.cell.2013.04.033.


Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth.

Yu M, Bell RH, Ho MM, Leung G, Haegert A, Carr N, Shapiro J, McElwee KJ.

PLoS One. 2012;7(5):e34185. doi: 10.1371/journal.pone.0034185. Epub 2012 May 16.


Dissociation of CAK from core TFIIH reveals a functional link between XP-G/CS and the TFIIH disassembly state.

Arab HH, Wani G, Ray A, Shah ZI, Zhu Q, Wani AA.

PLoS One. 2010 Jun 8;5(6):e11007. doi: 10.1371/journal.pone.0011007.


The TFIIH subunit p89 (XPB) localizes to the centrosome during mitosis.

Weber A, Chung HJ, Springer E, Heitzmann D, Warth R.

Cell Oncol. 2010;32(1-2):121-30. doi: 10.3233/CLO-2009-0509.


Telomere attrition and genomic instability in xeroderma pigmentosum type-b deficient fibroblasts under oxidative stress.

Ting AP, Low GK, Gopalakrishnan K, Hande MP.

J Cell Mol Med. 2010 Jan;14(1-2):403-16. doi: 10.1111/j.1582-4934.2009.00945.x. Epub 2009 Oct 16.


Phosphorylation of XPB helicase regulates TFIIH nucleotide excision repair activity.

Coin F, Auriol J, Tapias A, Clivio P, Vermeulen W, Egly JM.

EMBO J. 2004 Dec 8;23(24):4835-46. Epub 2004 Nov 18.


Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.

Terashita Y, Ishiguro H, Haruki N, Sugiura H, Tanaka T, Kimura M, Shinoda N, Kuwabara Y, Fujii Y.

Oncol Rep. 2004 Oct;12(4):827-31.


Reduced level of the repair/transcription factor TFIIH in trichothiodystrophy.

Botta E, Nardo T, Lehmann AR, Egly JM, Pedrini AM, Stefanini M.

Hum Mol Genet. 2002 Nov 1;11(23):2919-28.


Identification of four single nucleotide polymorphisms in DNA repair genes: XPA and XPB (ERCC3) in Polish population.

Butkiewicz D, Rusin M, Harris CC, Chorazy M.

Hum Mutat. 2000 Jun;15(6):577-8.


Xeroderma pigmentosum-Cockayne syndrome complex in two patients: absence of skin tumors despite severe deficiency of DNA excision repair.

Scott RJ, Itin P, Kleijer WJ, Kolb K, Arlett C, Muller H.

J Am Acad Dermatol. 1993 Nov;29(5 Pt 2):883-9.


Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3.

Vermeulen W, Scott RJ, Rodgers S, Müller HJ, Cole J, Arlett CF, Kleijer WJ, Bootsma D, Hoeijmakers JH, Weeda G.

Am J Hum Genet. 1994 Feb;54(2):191-200.


Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH).

van Vuuren AJ, Vermeulen W, Ma L, Weeda G, Appeldoorn E, Jaspers NG, van der Eb AJ, Bootsma D, Hoeijmakers JH, Humbert S, et al.

EMBO J. 1994 Apr 1;13(7):1645-53.


Molecular cloning and biological characterization of the human excision repair gene ERCC-3.

Weeda G, van Ham RC, Masurel R, Westerveld A, Odijk H, de Wit J, Bootsma D, van der Eb AJ, Hoeijmakers JH.

Mol Cell Biol. 1990 Jun;10(6):2570-81.


Structure and expression of the human XPBC/ERCC-3 gene involved in DNA repair disorders xeroderma pigmentosum and Cockayne's syndrome.

Weeda G, Ma LB, van Ham RC, van der Eb AJ, Hoeijmakers JH.

Nucleic Acids Res. 1991 Nov 25;19(22):6301-8.


Localization of the xeroderma pigmentosum group B-correcting gene ERCC3 to human chromosome 2q21.

Weeda G, Wiegant J, van der Ploeg M, Geurts van Kessel AH, van der Eb AJ, Hoeijmakers JH.

Genomics. 1991 Aug;10(4):1035-40.


Supplemental Content

Support Center